---
title: "Science Group (LON:SAG) Issues Quarterly Earnings Results"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/279436502.md"
description: "Science Group (LON:SAG) reported quarterly earnings of GBX 40.20 EPS, with a return on equity of 32.18% and a net margin of 26.97%. The stock opened at GBX 550, with a market capitalization of £235.31 million and a P/E ratio of 8.17. The company operates in consultancy services across various sectors including medical and aerospace. Despite a Buy rating, analysts suggest other stocks may be better investments."
datetime: "2026-03-17T12:57:53.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/279436502.md)
  - [en](https://longbridge.com/en/news/279436502.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/279436502.md)
generator: "portal-rs"
---

# Science Group (LON:SAG) Issues Quarterly Earnings Results

Science Group (LON:SAG - Get Free Report) issued its earnings results on Tuesday. The company reported GBX 40.20 earnings per share for the quarter, Digital Look Earnings reports. Science Group had a return on equity of 32.18% and a net margin of 26.97%.

Get **Science Group** alerts:

## Science Group Price Performance

Science Group stock opened at GBX 550 on Tuesday. The company has a debt-to-equity ratio of 13.88, a quick ratio of 1.56 and a current ratio of 2.40. Science Group has a 52 week low of GBX 400 and a 52 week high of GBX 605. The stock has a market capitalization of £235.31 million, a P/E ratio of 8.17 and a beta of 0.38. The stock has a fifty day moving average of GBX 542.94 and a 200-day moving average of GBX 546.84. 

## Science Group Company Profile

(Get Free Report)

Science Group plc, a science, engineering, and technology business company, provides consultancy services in the United Kingdom, rest of Europe, North America, Asia, and internationally. The company operates through three segments: Services Operating Business, Product Operating Business, and Freehold Properties. It offers advisory and product/technology development, scientific and regulatory advice, and registration and compliance services. It serves medical, defence and aerospace, food and beverage, consumer, industrial, chemical, and energy sectors.

## Read More

-   Five stocks we like better than Science Group
-   The gold chart Wall Street is terrified of…
-   Elon Musk already made me a “wealthy man”
-   Silver paying 20% dividend. Plus 68% share gains
-   Unlocked: Elon Musk’s Next Big IPO
-   1,500 Banks Just Handed the Fed Your Bank Account

*This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.*

## Should You Invest $1,000 in Science Group Right Now?

Before you consider Science Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Science Group wasn't on the list.

While Science Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

### Related Stocks

- [SAG.UK](https://longbridge.com/en/quote/SAG.UK.md)

## Related News & Research

- [Positive Report for Admiral (ADM) from Morgan Stanley](https://longbridge.com/en/news/298178420.md)
- [Spain's Ignis targets October IPO to raise up to €600 million, report says](https://longbridge.com/en/news/298175633.md)
- [Baidu’s Xiaodu schedules AI hardware launch for Sept. 8](https://longbridge.com/en/news/298171383.md)
- [Essity Advances SEK 3bn Share Buyback, Boosts Treasury Holdings](https://longbridge.com/en/news/298184582.md)
- [Andera Partners opens Frankfurt office to expand sponsorless mezzanine strategy in Germany](https://longbridge.com/en/news/298184844.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**